EPZM | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (221)

Latest Posts

About This Stock More About This Stock
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
Article By: ChinaBio® Today
Saturday, August 14, 2021 1:30 PM EDT
Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to $2.4 billion in milestones.
In this article: DYAI, SRNE, SGEN, CHRS, EPZM, HCM, 1801.HK, 1877.HK, 9995.HK, PHAS
Read
Morning Call For Wednesday, Oct. 3
Article By: Jim Van Meerten
Wednesday, October 3, 2018 8:11 AM EDT
Dec E-mini S&Ps (ESZ18 +0.32%) this morning are up +0.23% and European stocks are up +0.43% on a rally in Italian assets.
In this article: AN, GM, GOV, JCPNQ, TPX, ULBI, HCSG, EPZM, FANG, DTEA, TWLO, VVV, VBTX, SNBR, KALA
Read
Biotech Breakout: Healthcare Stocks Lead The Way
Article By: Rod Raynovich
Thursday, June 22, 2017 2:40 PM EDT
The BIO 2017 International Convention in San Diego got a big boost with investors piling into biotechnology and healthcare stocks. 2017 Biotech Run Has Been Impressive but what can we buy now?
In this article: XBI, XLV, IBB, AGIO, BLUE, BMY, CELG, CLVS, EPZM, EXEL, INCY, KITE, LOXO, MRK, NVS, PBYI, RHHBY, SGEN, TSRO
Read
Morning Call For March 14, 2016
Article By: Jim Van Meerten
Monday, March 14, 2016 8:59 AM EDT
Jun E-mini S&Ps (ESM16 -0.21%)are down -0.15% as investors focus on the outcome of the Fed's 2-day policy meeting that begins tomorrow.
In this article: CMA, NE, NX, RDC, CRUS, EQIX, TSLA, EPZM, CYBR, CC
Read

Latest Tweets for $EPZM

No tweets yet!

PARTNER HEADLINES